Pharmacokinetic study
Higher uptake
of curcuminoids.
“Bioavailability Study of Maxicuma Capsules Versus Micronized Curcumin Capsules as A Single Oral Dose in Fasted Healthy Adult Human Subjects.”Published · Current Research in Complementary & Alternative Medicine 7:191 (2023)
Study design.
- Design
- Crossover comparative pharmacokinetic study
- Participants
- 14 healthy adults
- Intervention
- Maxicuma® and micronized curcumin extract 95%, at an equal dose
- Measured
- The total curcuminoid profile in the blood: time to peak (Tmax), peak concentration (Cmax) and total exposure (AUC)
Key outcomes.
The results.
Maxicuma® is more bioavailable than micronized curcumin extract 95%, at an equal dose.
The publication.
Rachchh M, Gokani R, Patel H, Khamar J, Patel A. “Bioavailability Study of Maxicuma Capsules Versus Micronized Curcumin Capsules as A Single Oral Dose in Fasted Healthy Adult Human Subjects.” Current Research in Complementary & Alternative Medicine 7:191 (2023).
Full text available on request.
The other Maxicuma® study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Next step
Working with ?
Tell us the format and the market, and we will send a sample with its specification.